Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M69.9Revenue (TTM) $M119Net Margin (%)-39.1Altman Z-Score-4.7
Enterprise Value $M-22.7EPS (TTM) $-1.0Operating Margin %-39.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-39.2Higher ROA y-yY
Price/Book0.710-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %-13.0Current Ratio4.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-46.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M49.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 1.50-95%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 1.50-96%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 1.50-94%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.0086%$11.84 - $13.88
($12.85)
$ 1.50-88%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 1.50-81%Reduce -54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 1.50-81%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 1.50-77%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 1.50-76%Reduce -63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 1.50-76%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 1.50-73%Reduce -25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 1.50-73%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 1.50-77%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 1.50-75%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 1.50-78%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 1.50-81%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIOTECHNOLOGY VALUE FUND L P10% Owner 2017-01-03Buy4,379$1.3411.94view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-30Buy742,401$1.3411.94view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-20Buy654,921$1.3114.5view
KANGO SUJAYChief Commercial Officer 2016-12-13Sell75,000$1.2817.19view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.1926.05view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-86.28view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-86.33view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-88.29view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-87.68view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-90.63view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Infinity Provides 2017 Goals and Financial Guidance Jan 09 2017
Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy Jan 08 2017
Infinity To Present At 35th Annual J.P. Morgan Annual Healthcare Conference Jan 05 2017
Infinity Announces Organizational Changes Jan 04 2017
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 04 2017
Infinity Announces Organizational Changes Jan 04 2017
5 Stocks Insiders Love Right Now Dec 21 2016
How Health Insurance Innovations Inc (HIIQ) Stacks Up Against Its Peers Dec 19 2016
Is Infinity Pharmaceuticals Inc. (INFI) a Good Stock to Buy? Dec 10 2016
INFINITY PHARMACEUTICALS, INC. Financials Nov 17 2016
Infinis plc announces second quarter results for year ending 31.03.17 £350m 7% Senior Notes due... Nov 16 2016
Infinity (INFI) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo... Nov 10 2016
Blog Coverage Bristol-Myers Squibb and Infinity Pharma Collaborate for Clinical Trials to Test... Nov 10 2016
Edited Transcript of INFI earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Nov 09 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 09 2016
Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Nov 09 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)